NovoLog FlexPen Side Effects
NovoLog FlexPen | insulin aspart has been known to cause side effects such as
- Hypoglycemia
- Headache
- Nausea
- Hunger
- Confusion or weakness
- Drowsiness
- Dizziness
- Rapid heartbeat
- Sweating
- Inability to concentrate
Warnings & Recalls for NovoLog FlexPen
- NovoLog FlexPen can cause a serious condition known as hypokalemia, which is characterized by dry mouth, increased thirst and urination, irregular heartbeat, muscular pain, weakness, or discomfort, and confusion. Seek medical help immediately if any of these symptoms occur.
- Injection pens should never be shared, as this increases the risk of transference of diseases such as HIV or hepatitis.
- NovoLog has received a pregnancy Category B from the FDA. Although NovoLog is safe to use during pregnancy, it should not be used during breastfeeding as it is unknown whether the medication can be passed to a newborn child.
NovoLog FlexPen Treatment and Use
NovoLog FlexPen | insulin aspart is a portable, prefilled insulin pen manufactured by Novo Nordisk for the treatment of type 1 diabetes in adults and children at least 2 years of age or older. NovoLog FlexPen works to lower blood glucose levels, and is a fast-acting, short-term insulin injection that must be followed by a meal within 5 to 10 minutes of injection.
NovoLog FlexPen is typically used in conjunction used in conjunction with other insulin injections that are considered medium- or long-acting to control high glucose levels.
Other Names for NovoLog FlexPen
Brand Name:
Generic Name:
Lawsuits & Legal Information for NovoLog FlexPen
Author:
Lainee Hooks
Posted on May 19, 2012
